Simulations Plus, Inc.

Simulations Plus, Inc. is a provider of specialized **modeling and simulation software and consulting services** for the life sciences and related industries. The company focuses on tools that predict absorption, distribution, metabolism, excretion, and toxicity (ADMET), supporting drug discovery, preclinical and clinical development, and regulatory submissions. Its software portfolio includes platforms that integrate **artificial intelligence, machine learning, and physiologically based pharmacokinetic modeling**, enabling clients to simulate drug behavior in humans and animals, optimize formulations, and evaluate safety profiles before costly clinical trials. Simulations Plus, Inc. serves pharmaceutical and biotechnology companies, as well as organizations in chemicals, cosmetics, food ingredients, and agrochemicals, along with academic and regulatory bodies. By providing both software and data-driven consulting, the company plays an important role in **reducing development risk, shortening timelines, and enhancing decision-making** across the global drug development ecosystem.